19 studies found for:    Alkermes AND intramuscular (im) injections
Show Display Options
Rank Status Study
1 Recruiting Alcohol Pharmacotherapy for HIV+ Prisoners
Conditions: Alcohol Dependence;   Problem Drinking;   Hazardous Drinking;   Human Immunodeficiency Virus;   AIDS
Interventions: Drug: Vivitrol- Intramuscular naltrexone (depot-formulation);   Drug: Placebo
2 Completed
Has Results
ALK21-003: Study of Medisorb® Naltrexone (VIVITROL®) in Alcohol-Dependent Adults
Condition: Alcoholism
Interventions: Drug: Medisorb naltrexone 190 mg;   Drug: Medisorb naltrexone 380 mg;   Drug: Placebo matching Medisorb naltrexone 190 mg;   Drug: Placebo matching Medisorb naltrexone 380 mg
3 Completed
Has Results
ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use Opioids
Condition: Opiate Dependence
Interventions: Drug: Medisorb naltrexone 75 mg;   Drug: Medisorb naltrexone 150 mg;   Drug: Medisorb naltrexone 300 mg;   Drug: Hydromorphone (10 mg/mL);   Drug: Naloxone Challenge and Oral Naltrexone Tolerability Testing
4 Completed
Has Results
ALK21-014: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) After Enforced Abstinence
Condition: Alcohol Dependence
Interventions: Drug: VIVITROL 380 mg;   Drug: Placebo for VIVITROL 380 mg
5 Completed
Has Results
ALK21-006: Long-Term Study of Medisorb® Naltrexone (VIVITROL®)
Condition: Alcoholism
Interventions: Drug: Medisorb naltrexone 380 mg;   Drug: Oral naltrexone 50 mg
6 Completed
Has Results
ALK21-003EXT: An Extension of Study ALK21-003 (NCT01218958) to Test the Long-term Safety of Medisorb® Naltrexone (VIVITROL®)
Condition: Alcohol Dependence
Interventions: Drug: Medisorb naltrexone 190 mg;   Drug: Medisorb naltrexone 380 mg
7 Completed
Has Results
ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol-dependent Adults
Condition: Alcoholism
Interventions: Drug: Medisorb naltrexone 380 mg;   Drug: Medisorb naltrexone 190 mg
8 Terminated
Has Results
ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997])
Conditions: Alcoholism;   Opiate Dependence
Interventions: Drug: Medisorb naltrexone 380 mg;   Drug: Oral naltrexone to Medisorb naltrexone 380 mg
9 Recruiting Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM)
Condition: Amphetamine-Related Disorders
Interventions: Drug: extended-release naltrexone;   Drug: Placebo
10 Active, not recruiting A Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration
Condition: Opioid Dependence
Intervention: Drug: VIVITROL 380mg
11 Completed A Study of ALKS 9072 in Subjects With Chronic Stable Schizophrenia
Condition: Schizophrenia
Interventions: Drug: ALKS 9072, Low dose;   Drug: ALKS 9072, Med dose;   Drug: ALKS 9072, High dose;   Drug: Placebo
12 Completed A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil or ALKS 9070) in Subjects With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: ALKS 9072;   Drug: Placebo
13 Completed
Has Results
ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care Professionals
Condition: Opiate Dependence
Intervention: Drug: Medisorb naltrexone 380 mg
14 Completed
Has Results
ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence
Condition: Opiate Dependence
Interventions: Drug: VIVITROL® 380 mg;   Drug: Placebo
15 Completed Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Condition: Opiate Dependence
Interventions: Drug: Extended-Release Naltrexone;   Behavioral: Motivational Enhancement Counseling
16 Recruiting A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)
Condition: Schizophrenia
Interventions: Drug: ALKS 9072, Low;   Drug: ALKS 9072, High
17 Enrolling by invitation An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)
Condition: Schizophrenia
Interventions: Drug: ALKS 9072, Low Dose;   Drug: ALKS 9072, High Dose
18 Completed
Has Results
ALK21-018: Effects of Medisorb® Naltrexone (VIVITROL®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent Adults
Condition: Alcohol Dependence
Interventions: Drug: VIVITROL 380 mg;   Drug: Placebo
19 Recruiting Pre-Release VIVITROL for Opioid Dependent Inmates
Condition: Substance-Related Disorders
Intervention: Drug: naltrexone for extended release injectable suspension

Indicates status has not been verified in more than two years